Trigeminal Neuralgia research hub

An Efficacy and Safety Study of Basimglurant (NOE-101) in Patients With Trigeminal Neuralgia.

This study is testing a new medicine, basimglurant, for people aged 18-75 with trigeminal neuralgia (TN). We want to see if it's safe and helps reduce the pain. Half the participants will get the new medicine, and half will get a dummy pill (placebo).